Company: SMNR
Filing Date: 2025-12-03
Form Type: S-8
Source: 0001193125-25-306962
Chunk: 14

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: S-8
Chunk 14
---
 pursuant to applicable grants previously made irrespective of whether such grants are exercisable, vested or convertible as of the Determination Date or will become exercisable, vested or convertible within 60 days after the Determination Date. |

| (3) | Assumes all of the shares of Common Stock being offered are sold in the offering, that shares of Common Stock                                                                                                                                          
 beneficially owned by such Selling Stockholder on the Determination Date but not being offered pursuant to this Reoffer Prospectus (if any) are not sold, and that no additional shares are purchased or otherwise acquired other than pursuant to the 
 stock options relating to the shares being offered.                                                                                                                                                                                                    |

8

| (4) | Consists solely of shares of Common Stock issuable upon exercise of stock options granted pursuant to the Plan                                                                                                                                    
 that are exercisable within 60 days of the Determination Date. Until the date on which all payments and all obligations under that certain Senior Secured Promissory Note issued by Scilex Holding Company to Oramed Pharmaceuticals, Inc., dated 
 September 21, 2023 (as amended, the “Oramed Note”), has been paid in full in cash, the options will not be or become exercisable, eligible for exchange, redemption or repurchase, eligible to participate in any dividends or distributions      
 (including the proceeds of any corporate transaction) or have any voting rights in respect of, among other things, the Company or any of its respective current and future subsidiaries, successors and assigns.                                  |

| (5) | Consists of 21,875,000 shares of Common Stock issuable upon exercise of a stock option granted to Mr. Shah                                                                                                                                 
 pursuant to the Plan, of which 7,291,666 shares of Common Stock are exercisable within 60 days of the Determination Date, whereby 1/48th of the total amount of the shares vested and shall vest each month after the option grant date of 
 August 30, 2024, subject to Mr. Shah providing continuous service (as defined in the Plan) through each vesting date.                                                                                                                      |

| (6) | Consists of 21,875,000 shares of Common Stock issuable upon exercise of a stock option granted to Dr. Ji                                                                                                                                   
 pursuant to the Plan, of which 7,291,666 shares of Common Stock are exercisable within 60 days of the Determination Date, whereby 1/48th of the total amount of the shares vested and shall vest each month after the option